C12Y 203/01184
Acyl-homoserine-lactone synthase
Official title: Acyl-homoserine-lactone synthase (2.3.1.184)
C12Y203/01184 (Acyl-homoserine-lactone synthase) appears on 4 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 9
- Assignees
- 8
- Inventors
- 21
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Auto-induction regulatory system based on quorum sensing and application thereof21 Apr 2026US 12,606,835 B2Ocean Universrry of China
- Compositions and methods of using inducible signaling for tunable dynamics in microbial communities7 Apr 2026US 12,594,307 B2The Regents of the University of California
- Programmable bacteria for the treatment of cancer8 Jul 2025US 12,350,297 B2National Institutes of Health (NIH), U.S. Dept. of Health and Human Services (DHHS)
- Biofilms, components and methods of use to reduce biofouling and contamination8 Jan 2019US 10,172,362 B2The Penn State Research Foundation
- Compositions and methods for improved bioproduction2 Jul 2026US 2026/0185107 A1Nitto Denko Corporation
- Programmable Bacteria for the Treatment of Cancer8 Jan 2026US 2026/0007703 A1The Trustees of Columbia University in the City of New York
- Genetically modified bacteria resistant to mass cell lysis28 Aug 2025US 2025/0270603 A1Acies Bio d.o.o.
- Genetically modified methylotrophic bacteria producing lactate21 Aug 2025US 2025/0263731 A1Acies Bio d.o.o.
- Compositions and methods of using inducible signaling for tunable dyanmics in microbial communities9 Feb 2023US 2023/0044530 A1The Regents of the University of California
Most cited
By later US patents